Corxel Pharmaceuticals Denmark ApS: Financial statements 2025
CVR: 45430324
Source: annual report 2025, Danish Business Authority
21/02/2025 – 31/12/2025
Corxel Pharmaceuticals Denmark ApS (CVR 45430324) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2025 report amounted to DKK 40,000. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
- Employees
- 0
Official annual report
How creditworthy is Corxel Pharmaceuticals Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 21, 2025, Roderick Wong is registered as director of Corxel Pharmaceuticals Denmark ApS.
As of February 21, 2025, Yanping Mou is registered as director of Corxel Pharmaceuticals Denmark ApS.
As of February 21, 2025, is registered as an owner of Corxel Pharmaceuticals Denmark ApS with an ownership share of 100%.
Corxel Pharmaceuticals Denmark ApS was founded on February 21, 2025.
About Corxel Pharmaceuticals Denmark ApS
Corxel Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2025. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Roderick Wong and Yanping Mou. The company is owned by Corxel Pharmaceuticals Hong Kong Limited. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2025 report amounted to DKK 40,000.